In this issue:
Tumour-size-based end points not suitable as surrogates for overall survival
SAPPHIRE shows reduced PN with oxaliplatin discontinuation after FOLFOX6 induction
Anti-EGFR maintenance is inferior to chemotherapy/anti-EGFR in mCRC
Positive mesenteric node location is not prognostic in CC
Complete mesocolic excision for rightsided CC
Surgical resection after neoadjuvant chemoradiotherapy in esophageal cancer
Microsatellite instability as a biomarker in gastric cancer
QoL during palliative systemic therapy for esophagogastric cancer
A cancer center’s exercise-oncology program
ECLIPSE shows no benefit to Cy/GVAX + CRS-207 over chemotherapy in mPAC
Please login below to download this issue (PDF)